CRNX CRINETICS PHARMACEUTICALS INC Management Changes 8-K Filing 2025 - Management Change Crinetics Pharmaceuticals announced the appointment of Tobin Schilke as Chief Financial Officer effective February 28, 2025, with an annual salary of $540,000 and a bonus opportunity of 40% of his salary; he will receive 52,000 RSUs and a stock option for 80,000 shares. This follows the resignation of Marc Wilson, effective the same date, for personal reasons.Get access to all SEC 8-K filings of the CRINETICS PHARMACEUTICALS INC